Retraction
MicroRNA‑503 suppresses cell proliferation and invasion in osteosarcoma via targeting insulin‑like growth factor 1 receptor
Paper Information
Record ID:
33491
Author(s):
Journal:
Publication Date:
June 22, 2017
Retraction Date:
October 06, 2021
(4.1 years years ago)
Subjects:
Institution:
Department of Orthopedics, Third Xiangya Hospital of Central South University, Changsha, Hunan 410013, P.R. ChinaCountry:
🇨🇳 ChinaArticle Type:
Publisher:
Spandidos
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.3892/etm.2021.10845Additional Notes:
see also: https://pubpeer.com/publications/018D5B6B8B9B75113CA548AAC79048;
Citations (19)
19
Total Citations1
Post-Retraction(5.3%)
18
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
0
Within 1 year
1
After 2+ years
794
Days since retraction (latest)
Cancer nanomedicine: Recent developments in drug delivery systems and strategies to overcome eventual barriers to achieve a better outcome
Jeferson Gustavo Henn, Tanira Alessandra Silveira Aguirre, Michael Nugent et al. (4 authors)
Journal of Drug Delivery Science and Technology
Published: Dec 2023
3 citations
3 citations
794 days after retraction
TP53 in Biology and Treatment of Osteosarcoma
Kamil Synoradzki, Ewa Bartnik, Anna M. Czarnecka et al. (9 authors)
Cancers
Open Access
Published: Aug 2021
46 citations
46 citations
42 days before retraction
GH and IGF System: The Regulatory Role of miRNAs and lncRNAs in Cancer
Cecilia Catellani, Gloria Ravegnini, Chiara Sartori et al. (5 authors)
Frontiers in Endocrinology
Open Access
Published: Aug 2021
14 citations
14 citations
51 days before retraction
The Causes and Consequences of miR-503 Dysregulation and Its Impact on Cardiovascular Disease and Cancer
Yanjing He, Yin Cai, Pearl Pai et al. (5 authors)
Frontiers in Pharmacology
Open Access
Published: Mar 2021
18 citations
18 citations
212 days before retraction
The Causes and Consequences of Mir-503 Dysregulation and Its Impact on Cardiovascular Disease and Cancer
Yanjing He, Yin Cai, Pearl Pai et al. (5 authors)
Vide Leaf, Hyderabad eBooks
Open Access
Published: Jan 2021
11 citations
11 citations
278 days before retraction
The microRNA-424/503 cluster: A master regulator of tumorigenesis and tumor progression with paradoxical roles in cancer
Ye Wu, Wei Wang, Angang Yang et al. (4 authors)
Cancer Letters
Published: Aug 2020
11 citations
11 citations
409 days before retraction
MicroRNA‑652 promotes cell proliferation and osteosarcoma invasion by directly targeting KLF9
Yongping Jin, Yang Liu, Xia Li
Experimental and Therapeutic Medicine
Open Access
Published: Jul 2020
12 citations
12 citations
439 days before retraction
Advances in the role of miRNAs in the occurrence and development of osteosarcoma
Guanyu Zhang, Yiran Li, Jiasheng Xu et al. (4 authors)
Open Medicine
Open Access
Published: Jan 2020
4 citations
4 citations
644 days before retraction
Receptor Tyrosine Kinases in Osteosarcoma: 2019 Update
Edward M. Greenfield, Christopher D. Collier, Patrick J. Getty
Advances in experimental medicine and biology
Published: Jan 2020
12 citations
12 citations
644 days before retraction
Mechanisms of Vasculogenic Mimicry in Ovarian Cancer
Lízbeth Ayala-Domínguez, Leslie Olmedo‐Nieva, J. Omar Muñoz-Bello et al. (7 authors)
Frontiers in Oncology
Open Access
Published: Sep 2019
65 citations
65 citations
740 days before retraction
Targeting mutant TP53 as a potential therapeutic strategy for the treatment of osteosarcoma
Fan Tang, Li Min, Nicole A. Seebacher et al. (9 authors)
Journal of Orthopaedic Research®
Open Access
Published: Jan 2019
45 citations
45 citations
987 days before retraction
Glioma cell proliferation is inhibited by miR-342-3p, miR-377/E2F1 signaling pathway
Ying Hu, Chunling Chi
Neoplasma
Open Access
Published: Jan 2019
16 citations
16 citations
1009 days before retraction
lncRNAPVT1 targets miR-152 to enhance chemoresistance of osteosarcoma to gemcitabine through activating c-MET/PI3K/AKT pathway
Zeyu Sun, Yuekui Jian, Huan-Ye Zhu et al. (4 authors)
Pathology - Research and Practice
Published: Dec 2018
71 citations
71 citations
1029 days before retraction
miR‐32 promotes esophageal squamous cell carcinoma metastasis by targeting CXXC5
Yatian Liu, Dan Zong, Xuesong Jiang et al. (8 authors)
Journal of Cellular Biochemistry
Published: Oct 2018
20 citations
20 citations
1077 days before retraction
miR‑491‑5p inhibits osteosarcoma cell proliferation by targeting PKM2
Ting Chen, Yuyang Li, Wenliang Cao et al. (4 authors)
Oncology Letters
Open Access
Published: Sep 2018
28 citations
28 citations
1114 days before retraction
NEAT1 induces osteosarcoma development by modulating the miR‐339‐5p/TGF‐β1 pathway
Lin Zhang, Xiaoqing Lu, Xiaoqing Zhou et al. (6 authors)
Journal of Cellular Physiology
Published: Sep 2018
37 citations
37 citations
1122 days before retraction
The possible role of insulin-like growth factor-1 in osteosarcoma
Yusheng Li, Qing Liu, Hongbo He et al. (4 authors)
Current Problems in Cancer
Published: Sep 2018
34 citations
34 citations
1125 days before retraction
miR‑590‑5p inhibits tumor growth in malignant melanoma by suppressing YAP1 expression
Kuanhou Mou, Meiling Ding, Dan Han et al. (7 authors)
Oncology Reports
Open Access
Published: Aug 2018
11 citations
11 citations
1156 days before retraction
Insulin signaling modulates border cell movement in <i>Drosophila</i> oogenesis
Aditi Sharma, Sudipta Halder, Martina Felix et al. (6 authors)
Development
Open Access
Published: Jun 2018
6 citations
6 citations
1197 days before retraction
Quick Stats
Total Citations:
19
Years Since Retraction:
4.1 years
Open Access:
Yes
Last Checked:
Jul 24, 2025